The New Adrenal Stress Index™
The Adrenal Stress Index™ panel (ASI™) was introduced
in 1989 to evaluate stress, a leading cause of morbidity and mortality.
Recently, new tests were added to evaluate glycemic control using
multiple salivary insulin measurements, and evaluate adrenal capacity
to produce cortisol using 17-Hydroxyprogesterone. Tests included in
the panel are shown in Table 1.
A salivary assay of cortisol and DHEA, imbalances of which are associated
with ailments ranging from obesity and menstrual disorders to immune
deficiency and increased risk of cardiovascular disease.
A powerful and precise non-invasive assay,evaluates bioactive levels
of the body's important stress hormones, cortisol and DHEA. This profile
serves as a critical tool for uncovering biochemical imbalances that
can underly anxiety, chronic fatigue, obesity, diabetes and a host
of other clinical conditions. It's also a crucial tool for monitoring
DHEA and/or cortisone therapy.
ASI
$220 to order this test click
ADD
|
|
Changing amounts of DHEA and cortisol over an individual's lifetime
may signal important alterations in adrenal function that can profoundly
affect his/her energy levels, emotional state, disease resistance,
and general sense of well-being. That's because adrenal hormones exert
a profound influence on the body's carbohydrate, protein, and lipid
metabolism, immune response, thyroid function, cardiovascular health,
and overall resistance to stress.
The The New Adrenal Stress Index accurately measures
unbound levels of both cortisol and DHEA, and provides a complete
circadian analysis of cortisol activity. Controlled collection times
allow for accurate baseline testing and effective monitoring of hormone
replacement therapy. Saliva samples can be easily collected by the
patient at home or at work.
.
Therapeutic value: The test results facilitate the diagnosis of stress
maladaptation and adrenal fatigue. With this data, you can narrow
your choices to the most appropriate modalities of treatment.
DHEA(S):
Description: The panel measures the average DHEA(S)* level for the
day using multiple samples.
Therapeutic
value: The cortisol to DHEA relationship is presented in a visual
graph that highlights the degree of stress maladaptation. This information
helps determine the projected time for recovery, and the substances
(hormones, supplements, botanicals) that promote this recovery.
Cortisol to DHEA ratio regulates many functions as listed below.
* Salivary DHEA(S) is found at about 0.1% of its plasma concentration.
Serum fluctuations in DHEA(S) concentrations are accurately and
rapidly reflected in salivary levels (3). DHEA(S) indicates Free
Fractions of both DHEA & DHEA-Sulfate.
17-Hydroxyprogesterone
(17-OHP1):
Description: The panel measures 17-OHP1 level in order to evaluate
efficiency of conversion of adrenal precursors into cortisol. Certain
adrenal fatigue patients who are genetically predisposed to low
production of cortisol will not benefit from exogenous supplementation
of pregnenolone or progesterone.
Therapeutic
value: By identifying the sub-population of maladapted and adrenal
fatigued individuals who show impaired 17-OHP1 conversion to cortisol,
two things are avoided:
1. Treating these patients with precursors
(when instead they need cortisol supplements
to restore their adrenal health).
2.
Pursuing further pituitary related
tests and treatments (when they are
not needed in this subpopulation).
Insulin:
Description: The panel includes fasting and postprandial insulin
measurements. The insulin values are used to diagnose insulin resistance,
functional insulin deficit (Pre-Diabetes) and also correlate elevated
cortisol with insulin to help explain glycemic dysregulation problems.
(See Glycemic Dysregulation section)
Therapeutic
value: The combined results of insulin and cortisol can help in
designing an effective glycemic control treatment plan that may
include life style modifications, nutritional support and botanical
supplementation.
Secretory
IgA (SIgA):
Description: The panel evaluates mucosal immunity by using SIgA
as a stress impact biomarker. SIgA values are sensitive to increased
cortisol/DHEA ratio and sympathetic tone (See Diagram 2).
Therapeutic
value: By detecting depressed mucosal immune function in certain
patients, a number of therapeutic modalities may be invoked, ranging
from botanical supplementation to control of heart rhythm variability.
Gliadin
Antibodies:
Description: The panel includes a gliadin antibody measurement that
allows detection of subclinical grain intolerance in affected individuals,
even in the absence of overt celiac disease.
Therapeutic
value: This test allows objective identification of grain intolerant
patients, who should restrict their gluten intake to reduce inflammation
and adrenal stress.
Common Adrenal Related Symptom
Inadequate Adrenal Function-
Weight Loss / Anorexia
Progressive Fatigue / Lethargy
Hypoglycemia
Diffuse Muscle & Joint Pains
Hypercalcemia
Low Serum Sodium / Salt Cravings
Skin Hyperpigmentation
High Serum Potassium
Anemia / Lymphocytosis
Lightheadedness upon standing
Abdominal Pain / Diarrhea
Hyperactive Adrenals-
Weight gain / Truncal Obesity
Emotional Lability / Depression
Glucose Intolerance
Ins sulin Resistance
Osteopenia / Fractures
Hypertension / Sodium Retention
Thin hyper pigmented skin / Striae
Sleep Disturbance
Poor Concentration / Memory Loss
Menstrual Dysfunction / Impotence
Increased Blood Lipids
Clinical
Applications of the ASI™ Test
by Diagnos Tech
Chronic Pain/Fibromyalgia: An adequate adrenal response can maintain
a higher pain threshold (4). The ASI™ is used to evaluate
the stress impact of chronic pain and inflammation on adrenal adaptation.
A proper diagnosis of low cortisol or DHEA with circadian rhythm
disruption is imperative. Subsequent hormone replacement and rhythm
correction will improve the individual's pain tolerance (7, 8).
Chronic Fatigue syndrome (CFS): A common HPA axis defect in CFS
is impaired corticotrophin release (5). As a result low cortisol
and eventual adrenal atrophy may be observed. Depleted adrenals
with flat rhythms are often seen on the ASI™ panel (6). Simultaneous
use of several therapies can help improve the debilitating CFS.
Glycemic Dysregulation: Chronic hypoglycemia can
impair normal adrenal function by repetitive over-stimulation of
cortisol production. Recurring expo- sure to high cortisol will
impair insulin activity, and invariably lead to insulin resistance
and beta-cell exhaustion (Diabetes). The ASI™ panel investigates
the Insulin-Cortisol relationship under real life conditions to
allow targeted and meaningful interventions. This panel is useful
in the following clinical situations: rapid weight gain and obesity,
deranged blood lipids, sugar blues, early diabetes and associated
emotional disturbances.
Allergies/Autoimmune Disorders: Fifty years ago, Dr W. Jefferies
(Author of "Safe Uses of Cortisol") discovered that patients
with environmentally triggered allergies and autoimmune diseases
dramatically benefited when given cortisol for other purposes (9).
More recently, German researchers reported that disruption of the
adrenal axis and cytokine relationships lead to predisposition and
aggravation of autoimmune diseases (10). The findings of the ASI™
help identify patients with autoimmune diseases and adrenal problems
who can benefit from cortisol supplements.
Depression/ADD: Several recent publications (11, 12) report a hyperactive
HPA axis in depressed patients. Elevated midnight salivary cortisol
is now considered one of the best tests in diagnosing endogenous
depression. Other anomalies in cortisol rhythm usually accompany
the midnight elevation. On the other hand cortisol elevations and
rhythm disruptions throughout the day are typical of attention deficit
disorders (ADD). The anomalous cortisol findings in depression and
ADD can be successfully diagnosed with the ASI.™ Subsequent
interventions to rectify the time specific cortisol elevations (during
day or night) are usually effective when applied under proper supervision
(13, 14).
All lab tests can be done through the mail in the privacy of your
own home, except blood tests, we send you to a lab to have your
blood drawn for these. After you pay for the test we mail you the
kit, the results take two weeks, the test results will be mailed
to us and we will call you to go over the results, its that easy!
All tests include the consultation for the report of findings.Click
on test of interest on the right for more information.
Call our office for more details:
800-956-7083 OR 818-707-3126. |